Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 180, Issue 11, 2009, Pages 1076-1082

  Fens, Niki ^a   Zwinderman, Aeilko H ^a   Van Der Schee, Marc P ^a   De Nijs, Selma B ^a   Dijkers, Erica ^a   Roldaan, Albert C ^b   Cheung, David ^c   Bel, Elisabeth H ^a   Sterk, Peter J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

^c ALBERT SCHWEITZER HOSPITAL   (Netherlands)

Author keywords

Biomarkers; Diagnosis; Electronic nose; Exhaled breath; Volatile organic compounds

Indexed keywords

CORTICOSTEROID; VOLATILE ORGANIC COMPOUND;

ADULT; ARTICLE; ASTHMA; BREATH ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ELECTRONIC NOSE; EXPIRATORY RESERVE VOLUME; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; MALE; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; REPRODUCIBILITY; RISK ASSESSMENT; TIDAL VOLUME;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; CROSS-SECTIONAL STUDIES; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; SMOKING; VOLATILE ORGANIC COMPOUNDS; YOUNG ADULT;

EID: 72749090104     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200906-0939OC     Document Type: Article

References (45)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Wheel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-555. (Pubitemid 47403272)
2. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143-178.
3. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:418-424. (Pubitemid 36216426)
4. Decramer M, Selroos O. Asthma and COPD: differences and similarities. With special reference to the usefulness of budesonide/formoterol in a single inhaler (Symbicort) in both diseases. Int J Clin Pract 2005;59:385-398. (Pubitemid 40467880)
5. Guerra S. Overlap of asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2005;11:7-13. (Pubitemid 40189245)
6. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009;64:728-735.
7. Bhattacharya S, Srisuma S, Demeo DL, Shapiro SD, Bueno R, Silverman EK, Reilly JJ, Mariani TJ. Molecular biomarkers for quantitative and discrete COPD phenotypes. Am J Respir Cell Mol Biol 2009;40: 359-367.
8. Brasier AR, Victor S, Boetticher G, Ju H, Lee C, Bleecker ER, Castro M, Busse WW, Calhoun WJ. Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines. J Allergy Clin Immunol 2008;121:30-37.
9. Weston AD, Hood L. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J Proteome Res 2004;3:179-196. (Pubitemid 38500984)
10. Crameri R. The potential of proteomics and peptidomics for allergy and asthma research. Allergy 2005;60:1227-1237. (Pubitemid 41297517)
11. Sepper R, Prikk K. Proteomics: is it an approach to understand the progression of chronic lung disorders? J Proteome Res 2004;3:277-281. (Pubitemid 38500995)
12. Carraro S, Rezzi S, Reniero F, Heberger K, Giordano G, Zanconato S, Guillou C, Baraldi E. Metabolomics applied to exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2007; 175:986-990. (Pubitemid 46741749)
13. Pauling L, Robinson AB, Teranishi R, Cary P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci USA 1971;68:2374-2376.
14. Moser B, Bodrogi F, Eibl G, Lechner M, Rieder J, Lirk P. Mass spectrometric profile of exhaled breath-field study by PTR-MS. Respir Physiol Neurobiol 2005;145:295-300. (Pubitemid 40215660)
15. Buszewski B, Kesy M, Ligor T, Amann A. Human exhaled air analytics: biomarkers of diseases. Biomed Chromatogr 2007;21:553-566. (Pubitemid 46937852)
16. Phillips M, Altorki N, Austin JH, Cameron RB, Cataneo RN, Kloss R, Maxfield RA, Munawar MI, Pass HI, Rashid A, et al. Detection of lung cancer using weighted digital analysis of breath biomarkers. Clin Chim Acta 2008;393:76-84.
17. Gaspar EM, Lucena AF, Duro da Costa J, Chaves das Neves H. Organic metabolites in exhaled human breath-a multivariate approach for identification of biomarkers in lung disorders. J Chromatogr A 2009; 1216:2749-2756.
18. Machado RF, Laskowski D, Deffenderfer O, Burch T, Zheng S, Mazzone PJ, Mekhail T, Jennings C, Stoller JK, Pyle J, et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med 2005;171:1286-1291. (Pubitemid 40740737)
19. Lewis NS. Comparisons between mammalian and artificial olfaction based on arrays of carbon black-polymer composite vapor detectors. Acc Chem Res 2004;37:663-672.
20. Scott SM, James D, Ali Z. Data analysis for electronic nose systems. Microchim Acta 2006;156:183-207.
21. Friedrich MJ. Scientists seek to sniff out diseases: electronic "noses" may someday be diagnostic tools. JAMA 2009;301:585-586.
22. Dragonieri S, Annema JT, Schot R, van der Schee MP, Spanevello A, Carratu P, Resta O, Rabe KF, Sterk PJ. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer 2009;64:166-170.
23. Dragonieri S, Schot R, Mertens BJ, Le CS, Gauw SA, Spanevello A, Resta O, Willard NP, Vink TJ, Rabe KF, et al. An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol 2007;120:856-862. (Pubitemid 47542280)
24. Fens N, de Nijs SB, Roldaan AC, Dijkers E, Zwinderman AH, Bel EH, Sterk PJ. Successful distinction between asthma and COPD by molecular profiling of exhaled breath using electronic nose. Am J Respir Crit Care Med 2009;179:A5180.
25. Bateman ED, Bousquet J, FitzGerald M, Haahtela T, O'Byrne P, Ohta K, Paggiaro P, Pedersen SE, Soto-Quiroz M, Tan W-C, et al.; Global Initiative for Asthma. GINA report, global strategy for asthma management and prevention [Internet]. Bethesda, MD: NHLBI; 2008 (accessed 2009 May 1). Available from: http://www.ginasthma.com/Guidelineitem.asp??11=2&12=1&intld=1561
26. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, et al. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000;161:309-329. (Pubitemid 30055941)
27. Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community respiratory health survey. Eur Respir J 1994;7:954-960. (Pubitemid 24153598)
28. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-338.
29. Knottnerus JA, Muris JW. Assessment of the accuracy of diagnostic tests: the cross-sectional study. J Clin Epidemiol 2003;56:1118-1128. (Pubitemid 37386337)
30. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003;138:W1-W12.
31. Gluud C, Gluud LL. Evidence based diagnostics. BMJ 2005;330:724-726.
32. Shaham O, Carmel L, Harel D. On mappings between electronic noses. Sensors Actuators B 2005;106:76-82.
33. Mauad T, Dolhnikoff M. Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2008;14:31-38. (Pubitemid 350191036)
34. Van Berkel JJ, Dallinga JW, Moller GM, Godschalk RW, Moonen E, Wouters EF, Van Schooten FJ. Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air. J Chromatogr B Analyt Technol Biomed Life Sci 2008;861:101-107. (Pubitemid 350298064)
35. de Laurentiis G, Paris D, Melck D, Maniscalco M, Marsico S, Corso G, Motta A, Sofia M. Metabonomic analysis of exhaled breath condensate in adults by nu2clear magnetic resonance spectroscopy. Eur Respir J 2008;32:1175-1183.
36. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001;163:1693-1722.
37. Anderson GP. Endotyping asthma: 2new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008;372: 1107-1119.
38. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008; 31:1334-1356.
39. Fens N, de Nijs SB, Knobel H, Willard N, Verhaegh W, Vink A, Lutter R, Dijkers E, Krouwels FH, Sterk PJ. Exhaled breath molecular profiling using an electronic nose identifies eosinophilic inflammation in COPD [Abstract]. Am J Respir Crit Care Med 2009;179:A4324.
40. Jousilahti P, Salomaa V, Hakala K, Rasi V, Vahtera E, Palosuo T. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol 2002;89:381-385. (Pubitemid 36188009)
41. Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med (In press)
42. Wouters EF. Chronic obstructive pulmonary disease. 5: systemic effects of COPD. Thorax 2002;57:1067-1070. (Pubitemid 35440768)
43. Higashimoto Y, Yamagata Y, Taya S, Iwata T, Okada M, Ishiguchi T, Sato H, Itoh H. Systemic inflammation in chronic obstructive pulmonary disease and asthma: Similarities and differences. Respirology 2008;13:128-133.
44. Morrison D, Rahman I, Lannan S, MacNee W. Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. Am J Respir Crit Care Med 1999;159:473-479. (Pubitemid 29084868)
45. Paredi P, Kharitonov SA, Barnes PJ. Elevation of exhaled ethane concentration in asthma. Am J Respir Crit Care Med 2000;162:1450-1454. (Pubitemid 30826170)